Hims & Hers Health Inc’s recent filing unveils that its Officer Chi Michael acquired Company’s shares for reported $0.31 million on Feb 10 ’25. In the deal valued at $43.28 per share,7,259 shares were bought.
Then, Okupe Oluyemi sold 11,581 shares, generating $450,730 in total proceeds. Upon selling the shares at $38.92, the Chief Financial Officer now owns 112,933 shares.
Before that, Dudum Andrew sold 100,000 shares. Hims & Hers Health Inc shares valued at $3,522,300 were divested by the Chief Executive Officer at a price of $35.22 per share. As a result of the transaction, Dudum Andrew now holds 27,918 shares, worth roughly $1.25 million.
Citigroup downgraded its Hims & Hers Health Inc [HIMS] rating to a Sell from a a Neutral in a research note published on January 10, 2025; the price target was increased to $25 from $24. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. Morgan Stanley began covering HIMS with “an Overweight” recommendation on December 17, 2024. BofA Securities revised its rating on November 14, 2024. It rated HIMS as “an Underperform” which previously was an “a Buy”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 5.22% to $44.77. Over the last five days, the stock has gained 15.00%. Hims & Hers Health Inc shares have risen nearly 85.15% since the year began. Nevertheless, the stocks have risen 374.26% over the past one year. While a 52-week high of $46.01 was reached on 02/07/25, a 52-week low of $9.14 was recorded on 01/10/25. SMA at 50 days reached $30.88, while 200 days put it at $21.88.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 42.32, which if violated will result in even more drops to 39.88. On the upside, there is a resistance level at 46.20. A further resistance level may holdings at 47.62. The Relative Strength Index (RSI) on the 14-day chart is 80.07, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.35, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.07%. Stochastics %K at 84.24% indicates the stock is a selling.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2025-01-15, growing by 13.6 million shares to a total of 56.58 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 42.97 million shares. There was a rise of 24.05%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 22, 2024 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $24 price target.
